Search Results - "Kaplan, Barry H"

T1165 Use of Newer Agents in the Treatment of Gastric Adenocarcinoma by Somnay, Kaumudi, Kumar, Sandeep, James, Leonard P, Kaplan, Barry H

Get full text

Safety and Pain Palliation of Zoledronic Acid in Patients with Breast Cancer, Prostate Cancer, or Multiple Myeloma Who Previously Received Bisphosphonate Therapy by Vogel, Charles L., Yanagihara, Ronald H., Wood, Albert J., Schnell, Frederick M., Henderson, Charles, Kaplan, Barry H., Purdy, Malcolm H., Orlowski, Richard, Decker, Jodi L., Lacerna, Leo, Hohneker, John A.

“…An open‐label study conducted in community centers assessed the safety of zoledronic acid 4 mg intravenously over 15 minutes every 3–4 weeks as treatment of…”
Get full text

Single-center experience with paclitaxel (T), carboplatin (C), and capecitabine (X) in the treatment of advanced esophagogastric cancer by Ruoff, Carl Alex, Hong, Bennett, Kaplan, Barry H., Pollack, Simcha

“…Abstract only 116 Background: Epirubicin, cisplatin, and 5-FU (ECF) improves overall survival for advanced esopgagogastric adenocarcinoma compared with other…”
Get full text

Toxicity of cis-diamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydration by Vogl, S E, Zaravinos, T, Kaplan, B H

“…A two-hour program of hydration with 2 liters of 0.45% saline-5% dextrose and diuresis with furosemide and mannitol was employed to administer…”
Get more information

Mitomycin-C, methotrexate, bleomycin and cis-diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck by Vogl, S E, Lerner, H, Kaplan, B H, Camacho, F, Cinberg, J, Schoenfeld, D

“…Thirty-four patients with advanced squamous cancer of the head and neck were treated with an outpatient regimen combining mitomycin-C,…”
Get more information

Group Therapy with Patients in the Waiting Room of an Oncology Clinic by Arnowitz, Edward, Brunswick, Lynne, Kaplan, Barry H.

Get full text

Alternating drug combinations for advanced Hodgkin's disease

Get more information

Combination chemotherapy of advanced ovarian cancer with hexamethylmelamine, cis-Platinum, and doxorubicin after failure of prior therapy by Vogl, S E, Pagano, M, Kaplan, B H, Einhorn, N, Arseneau, J, Moukhtar, M, Greenwald, E

“…Forty-nine women received a combination of cis-platinum and hexamethylmelamine (36 also received doxorubicin) for advanced ovarian cancer progressing after…”
Get more information

The Inhibition of Sterol Biosynthesis in Rat Liver Homogenates by Bile by Ogilvie, J W, Kaplan, B H

“…The incorporation in vitro of acetate-1- 14 C into digitonin-precipitable sterols in rat liver homogenates is markedly inhibited by small amounts of rat bile…”
Get full text

Safe and effective two-hour outpatient regimen of hydration and diuresis for the administration of cis-diamminedichloroplatinum (II) by Vogl, S E, Zaravinos, T, Kaplan, B H, Wollner, D

Get more information

Polycythemia vera in a patient with acquired immunodeficiency syndrome by Taha, Hesham M., Kaplan, Barry H.

Get full text

Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens by Vogl, S E, Pagano, M, Kaplan, B H, Greenwald, E, Arseneau, J, Bennett, B

“…Thirty-eight women with advanced ovarian cancer were given monthly cycles of intravenous cyclophosphamide, Adriamycin (doxorubicin) and cis-platin, and oral…”
Get more information

Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group by Wiernik, P H, Yeap, B, Vogl, S E, Kaplan, B H, Comis, R L, Falkson, G, Davis, T E, Fazzini, E, Cheuvart, B, Horton, J

“…A total of 248 analyzable patients with Stages III-IV ovarian epithelial cancer (114 with and 134 without prior chemotherapy) were randomized to one of four…”
Get more information

Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule by Vogl, S E, Kaplan, B H

“…Thirty-one patients with advanced cancer of the head and neck, twenty-six of whom had failed prior irradiation, were treated with an out-patient chemotherapy…”
Get more information

A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer by Vogl, S E, Schoenfeld, D A, Kaplan, B H, Lerner, H J, Engstrom, P F, Horton, J

“…Combination chemotherapy with methotrexate, bleomycin, and cis-diamminedichloroplatinum (II) was compared to weekly therapy with methotrexate alone in a…”
Get more information

Failure of effective initial chemotherapy to modify the course of stage IV (MO) squamous cancer of the head and neck by Vogl, S E, Lerner, H, Kaplan, B H, Coughlin, C, McCormick, B, Camacho, F, Cinberg, J

“…Twenty-four patients with advanced squamous cancer of the head and neck without distant metastases were given combination chemotherapy including methotrexate,…”
Get more information

"Second-effort" surgical resection for bulky ovarian cancer by Vogl, S E, Seltzer, V, Calanog, A, Moukhtar, M, Camacho, F, Kaplan, B H, Greenwald, E

“…Eighteen women with bulky ovarian cancer at the start of chemotherapy were brought to second laparotomy after 6 months of combination chemotherapy in an effort…”
Get more information

Effective chemotherapy for esophageal cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II by Vogl, S E, Greenwald, E, Kaplan, B H

“…Ten patients with squamous cancer of the esophagus were treated with an outpatient regimen combining cis-diamminedichloroplatinum (II), methotrexate and…”
Get more information

Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinoma by Vogl, S E, Berenzweig, M, Camacho, F, Greenwald, E, Kaplan, B H

“…Thirty patients with advanced non-small cell bronchogenic carcinoma were treated with cis-platin, 75 mg/M2 weekly for three weeks, then every three weeks…”
Get more information

Adriamycin and cis-diamminedichloroplatinum in the treatment of metastatic endometrial adenocarcinoma by Seltzer, V, Vogl, S E, Kaplan, B H

“…Adriamycin (50 mg/m2) and cis-diamminedichloroplatinum (50 mg/m2) were administered every 21 days to treat metastatic endometrial adenocarcinoma. This regimen…”
Get more information